Company Pharma Plus Srl with Fiscal Code 16214540
recorded a turnover of 2024 of
493.316,
with a net profit of
33.533
and having an average number of employees of
5.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Pharma Plus Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
472.869
434.248
487.308
537.798
493.941
552.405
549.646
529.532
506.789
493.316
Total Income - EUR
474.755
434.518
488.034
541.221
494.880
552.475
550.271
563.255
506.794
493.326
Total Expenses - EUR
433.712
420.958
469.737
497.212
466.542
503.362
489.374
515.626
457.300
453.946
Gross Profit/Loss - EUR
41.043
13.560
18.297
44.008
28.338
49.114
60.897
47.629
49.494
39.380
Net Profit/Loss - EUR
34.177
10.558
8.673
36.674
23.967
42.399
51.541
40.256
42.856
33.533
Employees
6
6
5
5
5
6
6
6
5
5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -2.1%, from 506.789 euro in the year 2023, to 493.316 euro in 2024.
The Net Profit decreased by -9.084 euro, from 42.856 euro in 2023, to 33.533 in the last year.
Check the financial reports for the company - Pharma Plus Srl
Financial Rating - PHARMA PLUS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Pharma Plus Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Pharma Plus Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Pharma Plus Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Pharma Plus Srl - CUI 16214540
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
102.961
109.207
118.363
102.698
172.525
157.604
144.607
116.638
111.724
110.745
Current Assets
182.811
151.807
138.695
219.567
170.616
156.811
161.804
152.274
146.647
202.553
Inventories
63.457
57.538
33.633
30.101
45.055
45.685
45.781
53.559
57.224
67.362
Receivables
82.896
20.373
86.282
145.833
94.945
105.330
100.769
89.383
63.966
80.368
Cash
36.449
73.822
18.647
43.549
30.428
5.667
15.172
8.069
25.457
53.833
Shareholders Funds
94.467
70.233
77.145
103.890
76.840
94.270
104.073
92.950
135.525
85.774
Social Capital
45
45
9.851
9.670
9.483
9.303
9.097
9.125
9.097
9.046
Debts
190.761
190.243
179.383
217.855
266.301
220.145
202.338
175.961
122.847
227.523
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
202.553 euro in 2024 which includes Inventories of
67.362 euro, Receivables of
80.368 euro and cash availability of
53.833 euro.
The company's Equity was valued at
85.774 euro, while total Liabilities amounted to
227.523 euro.
Equity decreased by -48.993 euro, from 135.525 euro in 2023, to 85.774 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Pharma Plus Srl